论文部分内容阅读
陈瑞爱在接受中国经济网的采访时指出,我国近5年来生物药的比重一直停留在5%左右。目前在生物医药领域产品不足,支撑不了产业发展,同时产品缺乏也会导致产业水平不高,科研力量和生物医药成果产出不足。生物医药的研发需要较长时间,国家需要在人才建设方面加强完善。同时她建议生物药可以从保健品入手,可以做一些能够提高免疫力方面
In an interview with China Economic Net, Chen Rui-Ai pointed out that the proportion of biopharmaceuticals in China has remained at around 5% for the past five years. Currently lack of products in the field of biomedicine, can not support the development of the industry, while the lack of products will lead to the industry is not high, scientific research and bio-medicine output is insufficient. Biomedical research and development takes a long time, the country needs to strengthen and perfect the building of personnel. At the same time, she suggested that bio-medicine can start with health products and can do something that can enhance immunity